Interleukin Genetics Inc., of Waltham, Mass., said it received U.S. Patent No. 6,210,877. It covers certain IL-1 gene variations that increase the risk for heart disease.
Kosan Biosciences Inc., of Hayward, Calif., said it received U.S. Patent No. 6,204,388, by license from the Sloan-Kettering Institute for Cancer Research. It covers methods relating to the de novo chemical synthesis of epothilones.
Lexicon Genetics Inc., of The Woodlands, Texas, said it received U.S. Patent No. 6,207,371 titled ¿Indexed Library of Cells Containing Genomic Modification and Methods of Making and Utilizing the Same.¿ It covers gene trapping.
Merck & Co. Inc., of Whitehouse Station, N.J., received U.S. Patent Nos. 5,891,636; 5,716,785; 5,807,522 and 6,110,426 by license from Incyte Genomics Inc. The patents are for use in creating gene expression data microarrays and for internal manufacture of microarrays.
Progen Industries Ltd., of Brisbane, Australia, said it received U.S. Patent No. 6,207,402 titled ¿Detection of Mammalian Heparanase Activity and Purification of Mammalian Heparanase.¿ It covers a method for detecting mammalian heparanase activity in samples such as mammalian tissue, cells or bodily fluids.
Protogene Laboratories Inc., of Menlo Park, Calif., said it received U.S. Patent No. 6,210,894 titled ¿Method and Apparatus for Conducting an Array of Chemical Reactions on a Support Surface.¿ It covers methods of using functionalized microarrays for chemical reactions.